v3.26.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 07, 2026
Jul. 01, 2026
Jan. 08, 2026
Feb. 14, 2025
Jun. 30, 2026
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Aug. 14, 2026
Apr. 22, 2026
Apr. 21, 2026
Jan. 07, 2026
Oct. 17, 2025
Sep. 15, 2025
Jun. 04, 2025
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Reverse stock split     one-for-three reverse stock split                              
Common stock, shares authorized         13,333,333     13,333,333   13,333,333                
Common stock shares outstanding         2,856,860     2,856,860                    
Net credit to stockholders equity         $ 2,080,101 $ 2,060,312                        
Issuance costs withheld from ELOC proceeds               $ 638,282                  
Issuance of shares, value             $ 14,308,300                      
Principal amount                                 $ 2,000,000  
Share conversion           111,608                        
Disposition of nobility healthcare           $ 4,343,217                        
Stock-based compensation expense         63,615     112,586 23,565                  
Minimum bid price requirement in stockholders equity                             $ 2,500,000      
Stockholders equity         2,275,454 $ 4,294,506 11,569,375 2,275,454 8,151,705 $ 2,369,956               $ (9,013,430)
Stockholders equity               984,000                    
Proceeds from shares issued               4,004,659                  
Subsequent Event [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Common stock shares outstanding                     6,506,860              
Shares of common stock 3,250,000                                  
Number of shares issued 625,000 400,000                                
Number of shares issued for services debt satisfaction, and acquisitions 2,625,000                                  
Subsequent Event [Member] | ELOC [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of shares issued 1,025,000                                  
Proceeds from shares issued $ 975,039                                  
2025 Senior Secured Convertible Notes [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Principal amount         1,070,000     $ 1,070,000                    
Share conversion               111,608                    
Transition of derivative liability to equity upon note conversion               $ 1,357,253                    
ELOC Purchase Agreement [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Committed equity financing facility         20,400,000     20,400,000               $ 25,000,000    
Amortization of deferred issuance costs         256,308                          
Net credit to stockholders equity         2,080,101                          
Amortization total               502,528                    
Commitment fee percentage                               3.00%    
Committed equity financing facility amount                               $ 750,000    
Issuance of shares, value                   $ 227,792                
Number of shares issued                   22,802                
Commitment fee         $ 522,208     522,208                    
Underwriting Agreement [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Issuance of shares, value       $ 14,308,300                            
Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Common stock, shares authorized     66,666,667                 13,333,333 66,666,667 200,000,000        
Shares of common stock         2,330,000 277,000                        
Net credit to stockholders equity         $ 2,330 $ 277                        
Issuance of shares, value                                  
Number of shares issued         300,000   262                      
Stockholders equity         $ 2,857 527 $ 3 $ 2,857 115 $ 138              
Common Stock [Member] | ELOC Purchase Agreement [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Shares of common stock         2,330,000     2,607,000                    
Gross proceeds         $ 2,336,409     $ 4,642,941                    
Received in cash               4,004,659                    
Common Stock [Member] | Minimum [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Common stock shares outstanding                       2,633,063            
Common Stock [Member] | Maximum [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Common stock shares outstanding                       526,860            
Noncontrolling Interest [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Net credit to stockholders equity                                
Disposition of nobility healthcare           1,885,802                        
Stockholders equity         (1,194,675) (1,138,678) (1,885,802)               (1,198,286)
Retained Earnings [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Net credit to stockholders equity                                
Disposition of nobility healthcare           2,457,415                        
Stockholders equity         $ (152,159,104) $ (147,612,336) $ (133,249,457) $ (152,159,104) $ (137,794,658) $ (144,184,436)               $ (137,512,928)